Search

everythinglearnresearchcommunity

for

Search:↓

Customized medications made through compounding can be beneficial for various skin conditions but require careful regulation and collaboration between doctors and pharmacists.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Hair loss improved with treatment and successful transplant.

Hair analysis is better than urine and blood for detecting past drug use.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

The document reviews various hair and nail disorders, their causes, and treatments, emphasizing the need for proper diagnosis and the link between nail changes and systemic diseases.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Tacrolimus solution is effective and well-tolerated for treating inflammatory scalp conditions.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Vitamin D is crucial for skin health and managing skin diseases.

Oral minoxidil is as effective and safe as topical minoxidil for treating female pattern hair loss.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Terbinafine is the most effective medicine for fungal nail infections, especially for diabetics and those with weak immune systems.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Pubertal acne is linked to hormonal changes, affects quality of life, and is treated similarly to adult acne.

The document covers various dermatological treatments and conditions.

Most Cochrane Skin Group reviews are helpful for improving dermatology practices, but some lack enough evidence for clinical recommendations.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Obesity in the U.S. is largely influenced by diet and exercise, certain medications can improve heart procedures and hair growth, and major teaching hospitals have better patient outcomes.

Intramuscular injections improved hair density more than intradermal injections for treating hair loss.

Robotic hair transplantation with AI offers more reliable, precise, and efficient hair restoration.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Hydroxychloroquine may help COVID-19 patients with lupus.